The New Jersey Health + Life Science Exchange, or HELIX, is a $750 million research complex that will consist of three ...
Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. Jason Mast is a general assignment reporter at ...
Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop. A scheduled data review found the anti-tau antibody posdinemab failed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback